Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Routine Diagnostic Test for Lemierre Syndrome Is Required

By HospiMedica International staff writers
Posted on 09 Dec 2009
Physicians when diagnosing sore throat, or pharyngitis, in adolescents and young adults must consider the newly identified, potentially dangerous Fusobacterium necrophorum as the source of infection. More...
The bacterium can cause Lemierre syndrome, a potentially dangerous condition.

Symptoms of Lemierre syndrome include unilateral neck swelling, rigors, night sweats, or high fevers. Currently there is no routine test for F. necrophorum pharyngitis, and a CT scan is required to detect Lemierre syndrome. In the event that the disease is diagnosed, aggressive treatment with antibiotics such as a combination of penicillin and metronidazole or with clindamycin alone is appropriate.

Lemierre syndrome mostly affects adolescents and young adults and rarely is seen in preadolescents. It begins with a sore throat, followed by an infected jugular vein after four to five days. Abscesses in other parts of the body may occur. Approximately 5 percent of people who get Lemierre syndrome die.

Physicians are trained to suspect group A streptococcal bacteria as the primary cause of pharyngitis. But according to findings by investigators at the University of Alabama at Birmingham (UAB; USA), and published on December 1, 2009 in the Annals of Internal Medicine, sore throat in young adults and adolescents that worsens or is strep-negative, could be due to F. necrophorum. Although group A strep. is associated with rheumatic fever, the incidence and rate of Lemierre syndrome following exposure to F. necrophorum is much higher and associated with greater morbidity and mortality.

Robert Centor, M.D., professor of internal medicine, associate dean of medicine at UAB and the paper's lead author, said, "F. necrophorum, which only has been recognized as a potential cause of pharyngitis in adolescents and young adults in the past five years, may cause up to 10 percent of sore throat in those 15-24 years of age. More important, F. necrophorum is associated with a rare but life-threatening complication called Lemierre syndrome."

Prof. Centor added that he hopes this analysis will lead to better diagnostic tests for the presence of F. necrophorum.

Related Links:

University of Alabama at Birmingham



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.